196 related articles for article (PubMed ID: 37789966)
1. How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
Lu X; Zhang S
Drug Des Devel Ther; 2023; 17():2969-2983. PubMed ID: 37789966
[TBL] [Abstract][Full Text] [Related]
2. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
[TBL] [Abstract][Full Text] [Related]
3. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
Liang SB; Cao HJ; Kong LY; Wei JL; Robinson N; Yang SH; Zhu SJ; Li YQ; Fei YT; Han M; Liu JP
Front Pharmacol; 2022; 13():904657. PubMed ID: 36091782
[No Abstract] [Full Text] [Related]
5. Regulating effect of TongXie-YaoFang on colonic epithelial secretion
Yang C; Xiong Y; Zhang SS; An FM; Sun J; Zhang QL; Zhan Q
World J Gastroenterol; 2016 Dec; 22(48):10584-10591. PubMed ID: 28082810
[TBL] [Abstract][Full Text] [Related]
6. [Effect of electroacupuncture on visceral sensitivity and colonic NGF, TrkA, TRPV1 expression in IBS-D rats].
Yang YC; Zhou ZX; Xue T; Feng YH; Chen JT; Wang TN; Zhao JY; Wang LJ; Zhang P; Zhang LP; Ma HF
Zhongguo Zhen Jiu; 2022 Dec; 42(12):1395-402. PubMed ID: 36484193
[TBL] [Abstract][Full Text] [Related]
7. Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway.
Tan X; Pei W; Xie C; Wang Z; Liu J; Cheng Y; Mao T; Shi L; Zhao X; Lu Q; Sun Z; Kou F; Jiang H; Li J
Evid Based Complement Alternat Med; 2021; 2021():6679348. PubMed ID: 34239591
[TBL] [Abstract][Full Text] [Related]
8. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats.
Yang C; Zhang SS; Li XL; Wang ZF; Zhao LQ
World J Gastroenterol; 2015 Mar; 21(10):2912-7. PubMed ID: 25780288
[TBL] [Abstract][Full Text] [Related]
10. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
[TBL] [Abstract][Full Text] [Related]
11. Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor.
Long X; Li M; Li LX; Sun YY; Zhang WX; Zhao DY; Li YQ
Neurogastroenterol Motil; 2018 Apr; 30(4):e13227. PubMed ID: 29052293
[TBL] [Abstract][Full Text] [Related]
12. Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome.
Chen X; Yu X; Shi Y; Shen H
Ann Palliat Med; 2021 Aug; 10(8):9223-9232. PubMed ID: 34488410
[TBL] [Abstract][Full Text] [Related]
13. Involvement of enteric glial cells in colonic motility in a rat model of irritable bowel syndrome with predominant diarrhea.
Li Y; Li YR; Jin Y; Li MY; Zhang Q; Cao J; Li F; Zhang H; Chen J; Li YQ
J Chem Neuroanat; 2023 Mar; 128():102235. PubMed ID: 36669707
[TBL] [Abstract][Full Text] [Related]
14. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
[TBL] [Abstract][Full Text] [Related]
16. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.
Zhang C; Huang Y; Li P; Chen X; Liu F; Hou Q
BMC Complement Med Ther; 2020 Sep; 20(1):279. PubMed ID: 32928188
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine Tongxie Yaofang treating irritable bowel syndrome with diarrhea and type 2 diabetes mellitus in rats with liver-depression and spleen-deficiency: A preliminary study.
Xu W; Zhang Z; Lu Y; Li M; Li J; Tao W
Front Nutr; 2022; 9():968930. PubMed ID: 36438735
[TBL] [Abstract][Full Text] [Related]
18. EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome.
Zhang L; Wang R; Chen Y; Yang P; Bai T; Song J; Hou X
Life Sci; 2022 Apr; 295():120419. PubMed ID: 35183555
[TBL] [Abstract][Full Text] [Related]
19. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of Intestinal Homeostasis in Diarrhea-Predominant Irritable Bowel Syndrome by Electroacupuncture Through Submucosal Enteric Glial Cell-Derived S-Nitrosoglutathione.
Hou Y; Zhao Y; Jiang H; Wang K; Zhang W; Zhou S; Li Y; Zheng Q
Front Physiol; 2022; 13():917579. PubMed ID: 36105292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
